Evidence map›Paper›PMID 34911172›Full record

ReviewEndocrinology and metabolism (Seoul, Korea)2021

Serotonergic Regulation of Hepatic Energy Metabolism.

Jiwon Park, Wooju Jeong, Chahyeon Yun, Hail Kim, Chang-Myung Oh

Open access · diamondAbstract readReview
In one paragraph

Review in Endocrinology and metabolism (Seoul, Korea), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. [Mechanism ofNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. The Influence of BMP6 on Serotonin and Glucose Metabolism.International journal of molecular sciences · 2024
    Article
  9. Neural Stem Cell-based Regenerative Therapy: A New Approach to Diabetes Treatment.Endocrine, metabolic & immune disorders drug targets · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Serotonin in the regulation of systemic energy metabolism.Journal of diabetes investigation · 2022
    Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jiwon ParkDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea.
Wooju JeongDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea.
Chahyeon YunDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea.
Hail KimGraduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
Chang-Myung OhDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea.
Gwangju Institute of Science and Technology · KRKorea Advanced Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The liver is a vital organ that regulates systemic energy metabolism and many physiological functions. Nonalcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease and end-stage liver failure. NAFLD is primarily caused by metabolic disruption of lipid and glucose homeostasis. Serotonin (5-hydroxytryptamine [5-HT]) is a biogenic amine with several functions in both the central and peripheral systems. 5-HT functions as a neurotransmitter in the brain and a hormone in peripheral tissues to regulate systemic energy homeostasis. Several recent studies have proposed various roles of 5-HT in hepatic metabolism and inflammation using tissue-specific knockout mice and 5-HT-receptor agonists/antagonists. This review compiles the most recent research on the relationship between 5-HT and hepatic metabolism, and the role of 5-HT signaling as a potential therapeutic target in NAFLD.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsEnergy MetabolismHomeostasisMiceSerotoninSerotoninLiverNon-alcoholic fatty liver diseaseSerotonin

Identifiers

PMID34911172
PMCPMC8743581
OpenAlexW4200020805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.